Nel ASA's 253 Million NOK Order Haul Meets a 63% Revenue Slide

Nel ASA has handed investors a puzzle rather than a verdict. The hydrogen equipment maker's latest quarterly report showed order intake surging while revenue collapsed, and a broker downgrade has now sharpened the question of whether a fuller order book can be converted into actual business.

AlphaValue/Baader Europe cut its recommendation from "Buy" to "Add" on 16 October, according to media reports, and trimmed its price target to NOK 2.38 from NOK 3.82. The more cautious stance lands on a company whose third-quarter 2026 figures pointed in two directions at once.

A backlog that has yet to reach the top line

Revenue from customer contracts fell 63% to NOK 112 million in the quarter, a decline Nel attributed to lower activity in its alkaline business. Order intake, by contrast, jumped 339% to NOK 253 million, against NOK 57 million a year earlier. The order backlog stood at NOK 1,314 million.

That gap is the crux of the investment case. A rising backlog is a welcome signal on demand, but it does not by itself prove that day-to-day operations have turned a corner. For a credible recovery, the stronger order picture would need to show up in delivery, and then in earnings. Revenue from customer contracts remains the yardstick to watch; only when it picks up again does the distance between healthy orders and weak current activity begin to close.

Should investors sell immediately? Or is it worth buying Nel ASA?

The internal split is stark. PEM revenue climbed 65%, while alkaline revenue dropped 91%. The PEM advance offers a foothold for optimism, showing that not every part of the business is contracting at the same pace. A broader recovery, however, would require that progress to carry more weight or be matched by a stabilisation in alkaline.

Losses and a thinner cash cushion

The bottom line offers little comfort. EBITDA came in at NOK -93 million, compared with NOK -37 million a year earlier, and the net loss reached NOK -141 million. Cash at the end of the quarter was NOK 1,078 million, down from NOK 1.76 billion a year before.

That reserve still gives Nel room to manoeuvre, but it does not substitute for an earnings improvement, and the reduced buffer narrows the margin for error. Investors who focus only on the order growth would be taking a risk: as long as operations remain weak, the brighter order book has to be weighed against the losses. No reliable estimate of the company's financial runway can be drawn from the cash figure alone; what matters is whether Nel can contain its losses and preserve its reserves.

A US order, a Rheinmetall letter of intent

Two announcements in recent weeks add colour to the demand picture. Nel Hydrogen US received an order worth roughly USD 12 million from an unnamed US-based global technology company, covering several containerised PEM electrolysers and associated services. What counts for investors is less the customer's identity than the fact that a firm order exists rather than a mere statement of intent — though it yields no specific revenue timing or earnings contribution.

An agreement of a different kind came with Rheinmetall, with the two companies set to explore cooperation on decentralised production of renewable synthetic fuels. Business opportunities could follow, but the memorandum is non-binding and secures no follow-on order. It should be judged separately from the confirmed order intake.

Leadership handover sets the next checkpoint

Morten Holum was named CEO on Wednesday and is due to take the helm no later than 1 May 2027; according to FuelCellsWorks, he currently heads Hexagon Purus. Until then, an interim team carries the responsibility. CFO Kjell Christian Bjørnsen takes over as interim chief from 1 November 2026, with Torbjørn Berg stepping in as interim CFO, while Håkon Volldal leaves his executive duties at the end of October.

Nel ASA at a turning point? This analysis reveals what investors need to know now.

Those dates concern governance first, not proof of an operational turnaround. The interim leadership must run the business and prepare the ground for the handover, which means progress needs to be visible well before Holum arrives. Betting solely on the incoming CEO ignores the operating performance during the transition, and an experienced successor does not by itself fix a weak business.

The February print becomes the real test

The next hard datapoint is scheduled for 19 February 2027, when Nel reports again — a date that sits in the provisional calendar and is not yet final. By then the key question will be whether the gap between orders and revenue has narrowed. A broader improvement in the business and smaller operating losses would support the optimistic case; without such progress, the transition period would remain a stretch of heightened uncertainty.

So long as the backlog provides a foundation for rising activity, a stabilisation scenario stays plausible. Should execution stall or the order momentum fade, the risk of a longer spell of weakness would grow. Investors are not simply choosing between confidence and scepticism — they are weighing an expected recovery against the operating evidence that has yet to arrive.

Ad

Nel ASA Stock: New Analysis - 23 October

Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nel ASA analysis...